Harpoon Therapeutics competitorsClear all
Harpoon Therapeutics's top competitors include Olema Oncology, APEIRON Biologics, Coherus BioSciences and Aptevo Therapeutics.
| Save Comparison |  Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. |  APEIRON Biologics APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies. |  Coherus BioSciences Coherus BioSciences is a biopharmaceutical company that focuses on the biosimilar and immuno-oncology market. |  Aptevo Therapeutics Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. | |
Founding Date | Founding Date 2015 | Founding Date 2007 | Founding Date 2005 | Founding Date 2010 | Founding Date 2016 |
Type | Type Public | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations South San Francisco, US HQ Louisville, US South San Francisco, US | Locations San Francisco, US HQ San Francisco, US | Locations Wien, AT HQ | Locations Redwood City, US HQ Camarillo, US | Locations Seattle, US HQ |
Employees | Employees 45 | Employees 21 | Employees 34 | Employees 3102% decrease | Employees 1182% decrease |
Valuation ($) | Valuation ($) 217.3 m | Valuation ($) 1.1 b | Valuation ($) N/A | Valuation ($) 1.3 b | Valuation ($) 71.6 m |
Twitter followers | Twitter followers N/A | Twitter followers 162 | Twitter followers 687 | Twitter followers 3.8 k | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 13 | Number of tweets (last 30 days) 3 | Number of tweets (last 30 days) 7 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 1.2 | Average likes per tweet (last 30 days) 2 | Average likes per tweet (last 30 days) 2.4 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 76.92% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 340843 | Alexa Website Rank N/A | Alexa Website Rank 373696 | Alexa Website Rank 303596 | Alexa Website Rank 247617 |
Employee Rating | Employee Rating 4.8 | Employee Rating N/A | Employee Rating N/A | Employee Rating 4.4 | Employee Rating 4.5 |
Financial | |||||
Revenue (est.) | Revenue (est.) $17.4m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $475.8m (FY, 2020) | Revenue (est.) $4.3m (FY, 2020) |
Net income | Net income ($49.9m) (FY, 2020) | Net income ($4.3m) (FY, 2019) | Net income N/A | Net income $132.2m (FY, 2020) | Net income ($17.8m) (FY, 2020) |
Funding | |||||
Total funding raised | Total funding raised $ 130m | Total funding raised $ 145.1m | Total funding raised N/A | Total funding raised $ 174.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Olema Oncology
HQ
San Francisco, US
Employees
21
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View companyAPEIRON Biologics
HQ
Wien, AT
Employees
34
APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies.
View companyCoherus BioSciences
HQ
Redwood City, US
Employees
310↓ 2% decrease
Coherus BioSciences is a biopharmaceutical company that focuses on the biosimilar and immuno-oncology market.
View companyAptevo Therapeutics
HQ
Seattle, US
Employees
118↓ 2% decrease
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
View company